Guardant Health Receives European Approval Of Guardant360 CDx As Companion Diagnostic For AstraZeneca’s ETCAMAH

Benzinga · 1d ago
  • Guardant360 CDx can now help identify cancer mutations earlier and drive improved patient outcomes in major global geographies
    • This latest approval marks Guardant’s 31st CDx approval